NO931221D0 - Fremgangsmaate ved aktivering av blodkoagulasjonsfaktorer - Google Patents

Fremgangsmaate ved aktivering av blodkoagulasjonsfaktorer

Info

Publication number
NO931221D0
NO931221D0 NO931221A NO931221A NO931221D0 NO 931221 D0 NO931221 D0 NO 931221D0 NO 931221 A NO931221 A NO 931221A NO 931221 A NO931221 A NO 931221A NO 931221 D0 NO931221 D0 NO 931221D0
Authority
NO
Norway
Prior art keywords
blood coagulation
procedure
coagulation factors
activating blood
trypsin
Prior art date
Application number
NO931221A
Other languages
English (en)
Other versions
NO306351B1 (no
NO931221L (no
Inventor
Yendra Linnau
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of NO931221D0 publication Critical patent/NO931221D0/no
Publication of NO931221L publication Critical patent/NO931221L/no
Publication of NO306351B1 publication Critical patent/NO306351B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • External Artificial Organs (AREA)
  • Peptides Or Proteins (AREA)
NO931221A 1992-04-06 1993-03-31 FremgangsmÕte ved aktivering av blodkoagulasjonsfaktorer NO306351B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0071392A AT396937B (de) 1992-04-06 1992-04-06 Verfahren zur aktivierung von blutgerinnungsfaktoren

Publications (3)

Publication Number Publication Date
NO931221D0 true NO931221D0 (no) 1993-03-31
NO931221L NO931221L (no) 1993-10-07
NO306351B1 NO306351B1 (no) 1999-10-25

Family

ID=3497847

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931221A NO306351B1 (no) 1992-04-06 1993-03-31 FremgangsmÕte ved aktivering av blodkoagulasjonsfaktorer

Country Status (15)

Country Link
US (1) US5393666A (no)
EP (1) EP0565512B1 (no)
JP (1) JP2723445B2 (no)
AT (2) AT396937B (no)
AU (1) AU663573B2 (no)
CA (1) CA2092158A1 (no)
CZ (1) CZ279602B6 (no)
DE (1) DE59309217D1 (no)
DK (1) DK0565512T3 (no)
ES (1) ES2125971T3 (no)
FI (1) FI106562B (no)
HU (1) HU216316B (no)
NO (1) NO306351B1 (no)
PL (1) PL298391A1 (no)
SK (1) SK281266B6 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK83092D0 (da) * 1992-06-24 1992-06-24 Unes As Fremgangsmaade til udvinding af thrombin
US5795780A (en) * 1993-06-23 1998-08-18 Bristol-Myers Squibb Company Method of use of autologous thrombin blood fraction in a cell culture with keratinocytes
US5677162A (en) * 1995-05-01 1997-10-14 New York Blood Center, Inc. Method for activating prothrombin to thrombin
AT404597B (de) 1995-11-24 1998-12-28 Immuno Ag Verfahren zur herstellung von proteinen
WO2000062828A1 (en) * 1996-04-30 2000-10-26 Medtronic, Inc. Autologous fibrin sealant and method for making the same
US5844087A (en) 1996-11-05 1998-12-01 Bayer Corporation Method and device for delivering fibrin glue
US6274090B1 (en) 1998-08-05 2001-08-14 Thermogenesis Corp. Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
US6461834B1 (en) 1998-11-06 2002-10-08 Bionebraska, Inc. Clostripain catalyzed amidation of peptides
US6472162B1 (en) 1999-06-04 2002-10-29 Thermogenesis Corp. Method for preparing thrombin for use in a biological glue
SI1966371T1 (sl) * 2005-12-22 2011-11-30 Zymogenetics Inc Metoda za aktivacijo pretrombina-1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2757992A1 (de) * 1977-12-24 1979-06-28 Boehringer Mannheim Gmbh Verfahren zur prothrombin-bestimmung
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
JPS59225064A (ja) * 1983-06-03 1984-12-18 ユニチカ株式会社 生理活性物質固定化用担体
AT385657B (de) * 1984-03-09 1988-05-10 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
AT390560B (de) * 1986-05-30 1990-05-25 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
EP0294851A3 (de) * 1987-06-12 1990-05-09 Berlin-Chemie Ag Verfahren zur Herstellung von Humaninsulin und seinen Derivaten

Also Published As

Publication number Publication date
ATA71392A (de) 1993-05-15
DK0565512T3 (da) 1999-08-23
AU663573B2 (en) 1995-10-12
SK30893A3 (en) 1993-11-10
HU216316B (hu) 1999-06-28
EP0565512B1 (de) 1998-12-16
CZ53193A3 (en) 1994-01-19
CA2092158A1 (en) 1993-10-07
CZ279602B6 (cs) 1995-05-17
JP2723445B2 (ja) 1998-03-09
AT396937B (de) 1993-12-27
NO306351B1 (no) 1999-10-25
FI106562B (fi) 2001-02-28
DE59309217D1 (de) 1999-01-28
FI931554A0 (fi) 1993-04-06
NO931221L (no) 1993-10-07
JPH0686674A (ja) 1994-03-29
PL298391A1 (en) 1993-10-18
ES2125971T3 (es) 1999-03-16
ATE174624T1 (de) 1999-01-15
US5393666A (en) 1995-02-28
HU9300753D0 (en) 1993-06-28
SK281266B6 (sk) 2001-01-18
FI931554A (fi) 1993-10-07
AU3562293A (en) 1993-10-07
HUT68586A (en) 1995-06-28
EP0565512A1 (de) 1993-10-13

Similar Documents

Publication Publication Date Title
ATE194921T1 (de) Verfahren zur inaktivierung von viren
ATE161681T1 (de) Verfahren zur inaktivierung von viren in blut und blutprodukten
DE68922191D1 (de) Verfahren zur Produktion von Akrylat und von Akrylat enthaltendem Polymer.
DE69033509D1 (de) Laserverfahren zur Behandlung von Mikrokapseln oder Teilchen
NO931221L (no) Fremgangsmaate ved aktivering av blodkoagulasjonsfaktorer
DE3886179T2 (de) Verfahren zur Herstellung eines Silber enthaltenden Katalysators und Verfahren zur Epoxydierung von höheren Olefinen.
ATE85764T1 (de) Verfahren zur behandlung von industriellen gasen, die schwefelverbindungen enthalten.
ATA902789A (de) Verfahren zur katalytischen behandlung von abwasser
NO954148D0 (no) Fast katalysatorbestanddel, fremstilling derav, samt fremgangsmåte ved fremstilling av polyolerfiner
DE3781930D1 (de) Verfahren zur behandlung von organischen abfallstoffen und dafuer nuetzliche katalysator-/co-katalysator-zusammensetzung.
DE3761370D1 (de) Verfahren zur aktivierung von wasserstoffperoxid zur oxidationsbehandlung von schwer abbaubaren toxischen substanzen.
DE59207095D1 (de) Verfahren zur Herstellung von aktiviertem Protein C
DE3781279T2 (de) Verfahren zur behandlung von blut.
DE3667280D1 (de) Verfahren und katalysator zur oxydation von fluorierten olefinen.
ATE92539T1 (de) Mittel zur entschwefelung von eisenschmelzen und ein verfahren zur herstellung des mittels sowie ein verfahren zur entschwefelung von eisenschmelzen mit dem mittel.
DE68914324D1 (de) Verfahren zur Oxydation von Kohlenwasserstoffen unter Verwendung von Verteilung des oxydierenden Gases.
DE69021584D1 (de) Behandlung von abgas.
ATE107961T1 (de) Verfahren zur regeneration von pyridin-cofaktoren durch elektrochemische reduktion.
ATE71406T1 (de) Verfahren zur durchfuehrung enzymatischer oxidationen.
DE69002933D1 (de) Verfahren zur Regenerierung von Aktivkohle.
ATE107621T1 (de) Verfahren und katalysator zur enthalogenierung von alpha-halogenierten carbonsäuren.
ATE102846T1 (de) Mittel und verfahren zur reinigung von gasen und abgasen von schwermetallen und ein verfahren zur herstellung dieser mittel.
NO951039D0 (no) Fremgangsmåte ved fremstilling av en blandet persyreoksydasjonsopplösning, samt fremgangsmåter for behandling med denne
ATE85241T1 (de) Lanthanhaltiger katalysator zur behandlung von kraftfahrzeugabgasen.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees